Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Ajanta Pharma Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Otsuka Pharmaceutical Co., Ltd. v. Ajanta Pharma Ltd. (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-10-11 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 10,307,419; 7,888,362; 8,349,840; 8,618,109; 9,839,637 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Ajanta Pharma Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Otsuka Pharmaceutical Co., Ltd. v. Ajanta Pharma Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-10-11 | 1 | Complaint | the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637 (“the ’637 patent”), and 10,307,419 (“the ’…civil action for patent infringement of U.S. Patent Nos. 7,888,362 (“the ’362 patent”), 8,349,840 (“the… ’419 patent”) (collectively, “patents in suit”), arising under the United States patent laws, Title … The Patents In Suit 16. The United States Patent and Trademark Office …of the ’362 patent is attached as Exhibit A. 17. Otsuka owns the ’362 patent through assignment | External link to document |
| 2019-10-11 | 4 | Patent/Trademark Report to Commissioner of Patents | ,349,840; 8,618,109; 9,839,637; 10,307,419. (nmg) (Entered: 10/15/2019) 11 October 2019 PACER … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,888,362; 8,349,840… 11 October 2019 1:19-cv-01939 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
